HEADER APOPTOSIS 22-SEP-22 8EL0 TITLE STRUCTURE OF MBP-MCL-1 IN COMPLEX WITH A MACROCYCLIC COMPOUND COMPND MOL_ID: 1; COMPND 2 MOLECULE: MALTOSE/MALTODEXTRIN-BINDING PERIPLASMIC PROTEIN,INDUCED COMPND 3 MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL-1; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: MMBP,MALTODEXTRIN-BINDING PROTEIN,MALTOSE-BINDING PROTEIN, COMPND 6 MBP,BCL-2-LIKE PROTEIN 3,BCL2-L-3,BCL-2-RELATED PROTEIN EAT/MCL1, COMPND 7 MCL1/EAT; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI, HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 83333, 9606; SOURCE 5 STRAIN: K12; SOURCE 6 GENE: MALE, B4034, JW3994, MCL1, BCL2L3; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_VARIANT: T1R KEYWDS MBP-MCL-1 FUSION PROTEIN, APOPTOSIS, INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.A.JUDGE,A.S.JUDD,A.J.SOUERS REVDAT 2 08-NOV-23 8EL0 1 JRNL REVDAT 1 04-OCT-23 8EL0 0 JRNL AUTH J.YUDA,C.WILL,D.C.PHILLIPS,L.ABRAHAM,C.ALVEY,A.AVIGDOR, JRNL AUTH 2 W.BUCK,L.BESENHOFER,E.BOGHAERT,D.CHENG,D.COJOCARI,K.DOYLE, JRNL AUTH 3 T.M.HANSEN,K.HUANG,E.F.JOHNSON,A.S.JUDD,R.A.JUDGE, JRNL AUTH 4 J.C.KALVASS,A.KUNZER,L.T.LAM,R.LI,R.L.MARTIN,A.MASTRACCHIO, JRNL AUTH 5 M.MITTEN,A.PETRICH,J.WANG,J.E.WARD,H.ZHANG,X.WANG,J.E.WOLFF, JRNL AUTH 6 K.M.BELL-MCGUINN,A.J.SOUERS JRNL TITL SELECTIVE MCL-1 INHIBITOR ABBV-467 IS EFFICACIOUS IN TUMOR JRNL TITL 2 MODELS BUT IS ASSOCIATED WITH CARDIAC TROPONIN INCREASES IN JRNL TITL 3 PATIENTS. JRNL REF COMMUN MED (LOND) V. 3 154 2023 JRNL REFN ISSN 2730-664X JRNL PMID 37880389 JRNL DOI 10.1038/S43856-023-00380-Z REMARK 2 REMARK 2 RESOLUTION. 1.92 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.92 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 79.69 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 40543 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2055 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.92 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.93 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.23 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2609 REMARK 3 BIN FREE R VALUE : 0.3052 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 49 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4020 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 87 REMARK 3 SOLVENT ATOMS : 391 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.96 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.57610 REMARK 3 B22 (A**2) : 5.28060 REMARK 3 B33 (A**2) : -2.70450 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.230 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.177 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.147 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.165 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.143 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.945 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4206 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5708 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1460 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 758 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4206 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 546 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3940 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.86 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.05 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.67 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8EL0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-SEP-22. REMARK 100 THE DEPOSITION ID IS D_1000268697. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-MAR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS 20210205 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.7 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40544 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.917 REMARK 200 RESOLUTION RANGE LOW (A) : 79.690 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.92 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.90300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP 11.9.02 REMARK 200 STARTING MODEL: 4WMS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 26% (W/V) PEG 3350, 0.05 M MAGNESIUM REMARK 280 FORMATE, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 48.99500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 68.47150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 48.99500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 68.47150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -210 REMARK 465 ALA A -209 REMARK 465 HIS A -208 REMARK 465 HIS A -207 REMARK 465 HIS A -206 REMARK 465 HIS A -205 REMARK 465 HIS A -204 REMARK 465 HIS A -203 REMARK 465 GLU A -202 REMARK 465 ASN A -201 REMARK 465 LEU A -200 REMARK 465 TYR A -199 REMARK 465 PHE A -198 REMARK 465 GLN A -197 REMARK 465 GLY A -196 REMARK 465 VAL A 321 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A -24 CG CD OE1 OE2 REMARK 470 LYS A 238 CG CD CE NZ REMARK 470 ASP A 256 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A-141 -165.33 -108.02 REMARK 500 ALA A -28 -72.53 -82.29 REMARK 500 ASP A 13 -169.17 -116.96 REMARK 500 LYS A 238 -7.82 -149.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8EKX RELATED DB: PDB REMARK 900 8EKX CONTAINS THE SAME PROTEIN COMPLEXED WITH MIK665 DBREF 8EL0 A -195 170 UNP P0AEX9 MALE_ECOLI 27 392 DBREF 8EL0 A 173 321 UNP Q07820 MCL1_HUMAN 173 321 SEQADV 8EL0 MET A -210 UNP P0AEX9 INITIATING METHIONINE SEQADV 8EL0 ALA A -209 UNP P0AEX9 EXPRESSION TAG SEQADV 8EL0 HIS A -208 UNP P0AEX9 EXPRESSION TAG SEQADV 8EL0 HIS A -207 UNP P0AEX9 EXPRESSION TAG SEQADV 8EL0 HIS A -206 UNP P0AEX9 EXPRESSION TAG SEQADV 8EL0 HIS A -205 UNP P0AEX9 EXPRESSION TAG SEQADV 8EL0 HIS A -204 UNP P0AEX9 EXPRESSION TAG SEQADV 8EL0 HIS A -203 UNP P0AEX9 EXPRESSION TAG SEQADV 8EL0 GLU A -202 UNP P0AEX9 EXPRESSION TAG SEQADV 8EL0 ASN A -201 UNP P0AEX9 EXPRESSION TAG SEQADV 8EL0 LEU A -200 UNP P0AEX9 EXPRESSION TAG SEQADV 8EL0 TYR A -199 UNP P0AEX9 EXPRESSION TAG SEQADV 8EL0 PHE A -198 UNP P0AEX9 EXPRESSION TAG SEQADV 8EL0 GLN A -197 UNP P0AEX9 EXPRESSION TAG SEQADV 8EL0 GLY A -196 UNP P0AEX9 EXPRESSION TAG SEQADV 8EL0 GLY A 171 UNP P0AEX9 LINKER SEQADV 8EL0 SER A 172 UNP P0AEX9 LINKER SEQADV 8EL0 ALA A 194 UNP Q07820 LYS 194 ENGINEERED MUTATION SEQADV 8EL0 ALA A 197 UNP Q07820 LYS 197 ENGINEERED MUTATION SEQADV 8EL0 ALA A 201 UNP Q07820 ARG 201 ENGINEERED MUTATION SEQRES 1 A 532 MET ALA HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE SEQRES 2 A 532 GLN GLY LYS ILE GLU GLU GLY LYS LEU VAL ILE TRP ILE SEQRES 3 A 532 ASN GLY ASP LYS GLY TYR ASN GLY LEU ALA GLU VAL GLY SEQRES 4 A 532 LYS LYS PHE GLU LYS ASP THR GLY ILE LYS VAL THR VAL SEQRES 5 A 532 GLU HIS PRO ASP LYS LEU GLU GLU LYS PHE PRO GLN VAL SEQRES 6 A 532 ALA ALA THR GLY ASP GLY PRO ASP ILE ILE PHE TRP ALA SEQRES 7 A 532 HIS ASP ARG PHE GLY GLY TYR ALA GLN SER GLY LEU LEU SEQRES 8 A 532 ALA GLU ILE THR PRO ASP LYS ALA PHE GLN ASP LYS LEU SEQRES 9 A 532 TYR PRO PHE THR TRP ASP ALA VAL ARG TYR ASN GLY LYS SEQRES 10 A 532 LEU ILE ALA TYR PRO ILE ALA VAL GLU ALA LEU SER LEU SEQRES 11 A 532 ILE TYR ASN LYS ASP LEU LEU PRO ASN PRO PRO LYS THR SEQRES 12 A 532 TRP GLU GLU ILE PRO ALA LEU ASP LYS GLU LEU LYS ALA SEQRES 13 A 532 LYS GLY LYS SER ALA LEU MET PHE ASN LEU GLN GLU PRO SEQRES 14 A 532 TYR PHE THR TRP PRO LEU ILE ALA ALA ASP GLY GLY TYR SEQRES 15 A 532 ALA PHE LYS TYR GLU ASN GLY LYS TYR ASP ILE LYS ASP SEQRES 16 A 532 VAL GLY VAL ASP ASN ALA GLY ALA LYS ALA GLY LEU THR SEQRES 17 A 532 PHE LEU VAL ASP LEU ILE LYS ASN LYS HIS MET ASN ALA SEQRES 18 A 532 ASP THR ASP TYR SER ILE ALA GLU ALA ALA PHE ASN LYS SEQRES 19 A 532 GLY GLU THR ALA MET THR ILE ASN GLY PRO TRP ALA TRP SEQRES 20 A 532 SER ASN ILE ASP THR SER LYS VAL ASN TYR GLY VAL THR SEQRES 21 A 532 VAL LEU PRO THR PHE LYS GLY GLN PRO SER LYS PRO PHE SEQRES 22 A 532 VAL GLY VAL LEU SER ALA GLY ILE ASN ALA ALA SER PRO SEQRES 23 A 532 ASN LYS GLU LEU ALA LYS GLU PHE LEU GLU ASN TYR LEU SEQRES 24 A 532 LEU THR ASP GLU GLY LEU GLU ALA VAL ASN LYS ASP LYS SEQRES 25 A 532 PRO LEU GLY ALA VAL ALA LEU LYS SER TYR GLU GLU GLU SEQRES 26 A 532 LEU ALA LYS ASP PRO ARG ILE ALA ALA THR MET GLU ASN SEQRES 27 A 532 ALA GLN LYS GLY GLU ILE MET PRO ASN ILE PRO GLN MET SEQRES 28 A 532 SER ALA PHE TRP TYR ALA VAL ARG THR ALA VAL ILE ASN SEQRES 29 A 532 ALA ALA SER GLY ARG GLN THR VAL ASP GLU ALA LEU LYS SEQRES 30 A 532 ASP ALA GLN THR GLY SER GLU LEU TYR ARG GLN SER LEU SEQRES 31 A 532 GLU ILE ILE SER ARG TYR LEU ARG GLU GLN ALA THR GLY SEQRES 32 A 532 ALA ALA ASP THR ALA PRO MET GLY ALA SER GLY ALA THR SEQRES 33 A 532 SER ARG LYS ALA LEU GLU THR LEU ARG ARG VAL GLY ASP SEQRES 34 A 532 GLY VAL GLN ARG ASN HIS GLU THR ALA PHE GLN GLY MET SEQRES 35 A 532 LEU ARG LYS LEU ASP ILE LYS ASN GLU ASP ASP VAL LYS SEQRES 36 A 532 SER LEU SER ARG VAL MET ILE HIS VAL PHE SER ASP GLY SEQRES 37 A 532 VAL THR ASN TRP GLY ARG ILE VAL THR LEU ILE SER PHE SEQRES 38 A 532 GLY ALA PHE VAL ALA LYS HIS LEU LYS THR ILE ASN GLN SEQRES 39 A 532 GLU SER CYS ILE GLU PRO LEU ALA GLU SER ILE THR ASP SEQRES 40 A 532 VAL LEU VAL ARG THR LYS ARG ASP TRP LEU VAL LYS GLN SEQRES 41 A 532 ARG GLY TRP ASP GLY PHE VAL GLU PHE PHE HIS VAL HET GLC B 1 12 HET GLC B 2 11 HET WLW A4000 64 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM WLW (7R,20P)-18-CHLORO-1-(4-FLUOROPHENYL)-10-{[(2M)-2-(2- HETNAM 2 WLW METHOXYPHENYL)PYRIMIDIN-4-YL]METHOXY}-19-METHYL-15-[2- HETNAM 3 WLW (4-METHYLPIPERAZIN-1-YL)ETHYL]-7,8,15,16-TETRAHYDRO- HETNAM 4 WLW 14H-17,20-ETHENO-9,13-(METHENO)-6-OXA-2-THIA-3,5,15- HETNAM 5 WLW TRIAZACYCLOOCTADECA[1,2,3-CD]INDENE-7-CARBOXYLIC ACID HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 2 GLC 2(C6 H12 O6) FORMUL 3 WLW C49 H47 CL F N7 O5 S FORMUL 4 HOH *391(H2 O) HELIX 1 AA1 GLY A -180 GLY A -164 1 17 HELIX 2 AA2 LYS A -154 ALA A -144 1 11 HELIX 3 AA3 ARG A -130 SER A -123 1 8 HELIX 4 AA4 ASP A -114 ASP A -109 1 6 HELIX 5 AA5 TYR A -106 VAL A -99 1 8 HELIX 6 AA6 GLU A -65 ALA A -55 1 11 HELIX 7 AA7 GLU A -43 ASP A -32 1 12 HELIX 8 AA8 ASN A -11 ASN A 5 1 17 HELIX 9 AA9 ASP A 13 LYS A 23 1 11 HELIX 10 AB1 GLY A 32 TRP A 34 5 3 HELIX 11 AB2 ALA A 35 LYS A 43 1 9 HELIX 12 AB3 ASN A 76 TYR A 87 1 12 HELIX 13 AB4 THR A 90 LYS A 101 1 12 HELIX 14 AB5 LEU A 108 ALA A 116 1 9 HELIX 15 AB6 ASP A 118 GLY A 131 1 14 HELIX 16 AB7 GLN A 139 SER A 156 1 18 HELIX 17 AB8 THR A 160 GLY A 192 1 33 HELIX 18 AB9 SER A 202 HIS A 224 1 23 HELIX 19 AC1 HIS A 224 LEU A 235 1 12 HELIX 20 AC2 ASN A 239 GLY A 257 1 19 HELIX 21 AC3 ASN A 260 ILE A 281 1 22 HELIX 22 AC4 GLN A 283 SER A 285 5 3 HELIX 23 AC5 CYS A 286 LYS A 302 1 17 HELIX 24 AC6 LYS A 302 GLN A 309 1 8 HELIX 25 AC7 GLY A 311 PHE A 319 1 9 SHEET 1 AA1 6 LYS A-162 GLU A-158 0 SHEET 2 AA1 6 LYS A-190 TRP A-186 1 N ILE A-187 O GLU A-158 SHEET 3 AA1 6 ILE A-137 ALA A-133 1 O PHE A-135 N TRP A-186 SHEET 4 AA1 6 PHE A 62 ILE A 70 -1 O SER A 67 N TRP A-134 SHEET 5 AA1 6 TYR A -90 GLU A -85 -1 N GLU A -85 O GLY A 64 SHEET 6 AA1 6 ALA A 105 VAL A 106 -1 O ALA A 105 N VAL A -86 SHEET 1 AA2 5 LYS A-162 GLU A-158 0 SHEET 2 AA2 5 LYS A-190 TRP A-186 1 N ILE A-187 O GLU A-158 SHEET 3 AA2 5 ILE A-137 ALA A-133 1 O PHE A-135 N TRP A-186 SHEET 4 AA2 5 PHE A 62 ILE A 70 -1 O SER A 67 N TRP A-134 SHEET 5 AA2 5 GLU A 132 ILE A 133 1 O GLU A 132 N VAL A 63 SHEET 1 AA3 2 ARG A -98 TYR A -97 0 SHEET 2 AA3 2 LYS A -94 LEU A -93 -1 O LYS A -94 N TYR A -97 SHEET 1 AA4 4 SER A -51 LEU A -49 0 SHEET 2 AA4 4 THR A 26 ASN A 31 1 O ALA A 27 N SER A -51 SHEET 3 AA4 4 SER A -82 ASN A -78 -1 N ASN A -78 O ALA A 27 SHEET 4 AA4 4 TYR A 46 THR A 49 -1 O THR A 49 N LEU A -81 SHEET 1 AA5 2 TYR A -29 TYR A -25 0 SHEET 2 AA5 2 TYR A -20 GLY A -14 -1 O ASP A -16 N LYS A -26 LINK O4 GLC B 1 C1 GLC B 2 1555 1555 1.41 CRYST1 97.990 136.943 38.387 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010205 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007302 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026050 0.00000